LY2189102

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2189102, covering 2018-03-13 to 2018-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2189102 in Patients With Type 2 Diabetes [Phase 2]